Cargando…

Longitudinal characterization of biomarkers for spinal muscular atrophy

OBJECTIVE: Recent advances in understanding Spinal Muscular Atrophy (SMA) etiopathogenesis prompted development of potent intervention strategies and raised need for sensitive outcome measures capable of assessing disease progression and response to treatment. Several biomarkers have been proposed;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonati, Ulrike, Holiga, Štefan, Hellbach, Nicole, Risterucci, Céline, Bergauer, Tobias, Tang, Wakana, Hafner, Patricia, Thoeni, Alain, Bieri, Oliver, Gerlach, Irene, Marquet, Anne, Khwaja, Omar, Sambataro, Fabio, Bertolino, Alessandro, Dukart, Juergen, Fischmann, Arne, Fischer, Dirk, Czech, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420809/ https://www.ncbi.nlm.nih.gov/pubmed/28491897 http://dx.doi.org/10.1002/acn3.406

Ejemplares similares

Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients
por: Chen, Xing, et al.
Publicado: (2017)

Distinct Role of Striatal Functional Connectivity and Dopaminergic Loss in Parkinson’s Symptoms
por: Dukart, Juergen, et al.
Publicado: (2017)

The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease
por: Lorio, Sara, et al.
Publicado: (2019)

Test-retest reliability of task-based and resting-state blood oxygen level dependence and cerebral blood flow measures
por: Holiga, Štefan, et al.
Publicado: (2018)

Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data
por: Taylor, Kirsten I., et al.
Publicado: (2018)

Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study
por: Hafner, Patricia, et al.
Publicado: (2016)

When Structure Affects Function – The Need for Partial Volume Effect Correction in Functional and Resting State Magnetic Resonance Imaging Studies
por: Dukart, Juergen, et al.
Publicado: (2014)

Cerebral blood flow predicts differential neurotransmitter activity
por: Dukart, Juergen, et al.
Publicado: (2018)

Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls
por: Czech, Christian, et al.
Publicado: (2015)

Natural history of Type 2 and 3 spinal muscular atrophy: 2‐year NatHis‐SMA study
por: Annoussamy, Mélanie, et al.
Publicado: (2020)

Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial
por: Hafner, Patricia, et al.
Publicado: (2016)

O4.3. INCREASED CEREBRAL BLOOD FLOW AFTER SINGLE DOSE OF ANTIPSYCHOTICS IN HEALTHY SUBJECTS DEPENDS ON DOPAMINE D2 RECEPTOR DENSITY PROFILES EVALUATED WITH PET AND MRNA EXPRESSION DATA.
por: Selvaggi, Pierluigi, et al.
Publicado: (2018)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Progressive Muscular Atrophy
por: Omar, A.
Publicado: (1947)

Progressive Muscular Atrophy
por: Omar, A.
Publicado: (1947)

Progressive Muscular Atrophy
por: Omer, M. A.
Publicado: (1949)

Muscular Atrophy and Sclerodermia
por: Nixon, J. A.
Publicado: (1903)

Progressive Muscular Atrophy
Publicado: (1874)

Muscular Atrophy and Sclerodermia
Publicado: (1904)

Acute Muscular Atrophy
por: Haddon, John
Publicado: (1870)

Case of Muscular Atrophy
por: Kersey, V.
Publicado: (1871)

Case of Marked Muscular Atrophy of Hands and Fore-Arms—Progressive Muscular Atrophy(?)
por: Ness, R. Barclay
Publicado: (1895)

The effect of risperidone on reward‐related brain activity is robust to drug‐induced vascular changes
por: Hawkins, Peter C. T., et al.
Publicado: (2021)

An Objective and Child-friendly Assessment of Arm Function by Using a 3-D Sensor
por: Chen, Xing, et al.
Publicado: (2018)

Editorial: Spinal Muscular Atrophy: Evolutions and Revolutions of Modern Therapy
por: Finkel, Richard S., et al.
Publicado: (2020)

Effect of Combination l-Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
por: Hafner, Patricia, et al.
Publicado: (2019)

Real World Evidence on the Effectiveness of Nusinersen within the National Program to Treat Spinal Muscular Atrophy in Poland
por: Krupa, Dominika, et al.
Publicado: (2023)

Pseudo-Muscular Hypertrophy and Its Relations to Muscular Atrophy
Publicado: (1875)

Neuronal involvement in muscular atrophy
por: Cisterna, Bruno A., et al.
Publicado: (2014)

Muscular Atrophies in Joint Disease
Publicado: (1904)

Progressive Muscular Atrophy with Recovery
por: Clarke, J. Michell
Publicado: (1888)

Muscular Atrophy in Tabes Dorsalis
Publicado: (1889)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

A Case of Progressive Muscular Atrophy
por: Das, Kedarnath
Publicado: (1894)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_amh6aka84g0amar7e9quj8msfm